Болезнь Осгуда — Шлаттера — как улучшить результаты лечения?

Abstract

The study is aimed at improving treatment of Osgood — Schlatter disease by reducing periods of pain relief and clinical and radiological recovery, minimizing the relapses of the disease and rehabilitation period. The study involved 70 people (aged from 8 to 18 y.o., the mean age 13 y.o.) with a diagnosis of Osgood — Schlatter disease, types 1-4, based on clinical and radiological data. The patients were divided into two groups: basic and control ones, both receiving comprehensive treatment, which included lifestyle correction, physiotherapy, and therapeutic exercises for the knee joints. In addition, each patient of the basic group received one injection of platelet-rich autoplasma, and as a result, in 3 days after the injection the pain syndrome completely stopped. In the control examination one week after the injection, the edema in the upper third of the leg significantly decreased, and the range of motion in the knee joint fully restored. Three months after the injection, all adolescents returned to active lifestyle, physical activity and sports. Complications and relapses of the disease were not observed during monitoring for 12 months. The use of platelet-rich autoplasma stimulating reparative osteogenesis for the treatment of Osgood — Schlatter disease (types 1-4) results in highly effective treatment due to minimally invasive intervention, shortening the time of pain syndrome, and shortening the period of rehabilitation and return to active lifestyle.